Anidulafungin Dealers

• Brand: Endfund
• Packaging Size: 100 Mg/Vial
• Composition: Anidulafungin For Injection
• Treatment: Severe Fungal Infections
• Form: Injection
• Manufacturer: GSK

• Type: Anti Fungal Drugs
• Brand Name: Endfung
• Application: Clinic, Personal
• Packaging Size: Vial
• Brand Name: Endfung
• Manufacturer: Glenmark
• Composition: Anidulafungin
• Treatment: Severe fungal infections
• Strength: 100mg

Endfung 100 mg Injection kills fungus by preventing them from making their protective covering.  

• Brand Name: Andulfa 100
• Form: Liquid
• Type: Allopathic
• Country of Origin: India
• Strength: 100 mg
• Composition: Anidulafungin
• Manufactured By: Intas

Andulfa 100mg Injection is an antifungal medication. It is used in the treatment of severe fungal infections. It kills the fungi that cause infections and thus provides relief.Andulfa 100mg Injection is administered as an injection by a healthcare professional. Kindly do not self-administer. Do not skip any doses and finish the full course of treatment even if you feel better. Your liver function should be monitored regularly during treatment.It may lead to a few common side effects like decreased potassium levels in the blood, nausea, diarrhea, headache, and vomiting. You may also notice some injection site reactions like pain, swelling, or redness. Inform your doctor if these side effects persist. Please consult your doctor if you are pregnant, planning to conceive, or breastfeeding.

• CATEGORY: Anti-Fungal Drugs
• Dosage: 5mg
• Grade Standard: Medicine Grade
• Storage: Cool and Dry Place
• Form: Tablets / Liquid / Capsules / Powder
• Packaging Type: Plastic Bottle
• Storage: Cool and Dry Place
• Usage: Clinical, hospital etc.

Anidulafungin   injection is a sterile, lyophilized product for intravenous (IV) infusion that contains anidulafungin. Anidulafungin is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is an echinocandin, a class of antifungal drugs that inhibits the synthesis of 1,3-β-D-glucan, an essential component of fungal cell walls.   ADDITIONAL INFORMATION Increased levels of hepatic enzymes have been seen in healthy subjects and patients treated with anidulafungin. In some patients with serious underlying medical conditions who were receiving multiple concomitant medicines along with anidulafungin, clinically significant hepatic abnormalities have occurred. Cases of significant hepatic dysfunction, hepatitis, and hepatic failure were uncommon in clinical trials. Patients with increased hepatic enzymes during anidulafungin therapy should be monitored for evidence of worsening hepatic function and evaluated for risk/benefit of continuing anidulafungin therapy. Reconstitution 50 mg/vialAseptically reconstitute each 50 mg vial with 15 mL of sterile Water for Injection to provide a concentration of 3.33 mg/mL. The reconstituted solution can be stored for up to 24 hours at temperatures up to 25°C (77°F) prior to dilution into the infusion solution. Reconstitution 100 mg/vialAseptically reconstitute each 100 mg vial with 30 mL of sterile Water for Injection to provide a concentration of 3.33 mg/mL. The reconstituted solution can be stored for up to 24 hours at temperatures up to 25°C (77°F) prior to dilution into the infusion solution.   SIDE EFFECTS Stop using anidulafungin and call your doctor at once if you have a serious side effect such as: bronchospasm (wheezing, chest tightness, trouble breathing); fever, chills, body aches, flu symptoms, sores in your mouth and throat; nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).